ATE442139T1 - 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren - Google Patents
3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitorenInfo
- Publication number
- ATE442139T1 ATE442139T1 AT04723448T AT04723448T ATE442139T1 AT E442139 T1 ATE442139 T1 AT E442139T1 AT 04723448 T AT04723448 T AT 04723448T AT 04723448 T AT04723448 T AT 04723448T AT E442139 T1 ATE442139 T1 AT E442139T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- sup
- alkyl
- alkynyl
- alkenyl
- Prior art date
Links
- 239000003428 phospholipase inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000003342 alkenyl group Chemical group 0.000 abstract 5
- 125000000304 alkynyl group Chemical group 0.000 abstract 5
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000001188 haloalkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 102100031375 Endothelial lipase Human genes 0.000 abstract 2
- 101710087274 Endothelial lipase Proteins 0.000 abstract 2
- 102000019267 Hepatic lipases Human genes 0.000 abstract 2
- 108050006747 Hepatic lipases Proteins 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000019626 lipase activity Nutrition 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- -1 wherein the Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45936203P | 2003-03-31 | 2003-03-31 | |
| PCT/US2004/006092 WO2004093872A1 (en) | 2003-03-31 | 2004-03-25 | 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442139T1 true ATE442139T1 (de) | 2009-09-15 |
Family
ID=33310703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04723448T ATE442139T1 (de) | 2003-03-31 | 2004-03-25 | 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060211755A1 (de) |
| EP (1) | EP1610779B1 (de) |
| AT (1) | ATE442139T1 (de) |
| DE (1) | DE602004023062D1 (de) |
| ES (1) | ES2330636T3 (de) |
| WO (1) | WO2004093872A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004005172A1 (de) * | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
| DE102005048897A1 (de) | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen |
| DE102005049953A1 (de) * | 2005-10-19 | 2007-04-26 | Sanofi-Aventis Deutschland Gmbh | Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen |
| DE102006014688A1 (de) * | 2006-03-28 | 2007-10-04 | Sanofi-Aventis | Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
| EP2144885B1 (de) | 2007-04-05 | 2016-06-29 | Sanofi | Imidazolidin-carbonsäureamid-derivate als inhibitoren von lipasen und phospholipasen |
| RU2009140760A (ru) | 2007-04-05 | 2011-05-10 | Санофи-Авентис (Fr) | 5-оксоизоксазолы в качестве ингибиторов липаз и фосфолипаз |
| WO2008141385A1 (en) * | 2007-05-21 | 2008-11-27 | Biota Scientific Management Pty Ltd | Viral polymerase inhibitors |
| EP2351744B1 (de) * | 2008-10-17 | 2015-01-07 | Shionogi & Co., Ltd. | Essigsäureamidderivat mit hemmender wirkung auf vaskuläre endothellipase |
| CA2784710A1 (en) | 2009-12-15 | 2011-06-23 | Shionogi & Co., Ltd. | Oxadiazole derivative having endothelial lipase inhibitory activity |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| JP5902299B2 (ja) * | 2011-07-26 | 2016-04-13 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | Ｐａｒｐ−１阻害剤としての３−オキソ−２，３−ジヒドロ−１ｈ−インダゾール−４−カルボキサミド誘導体 |
| US9493412B2 (en) | 2011-09-27 | 2016-11-15 | Bristol-Myers Squibb Company | Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| WO2013049096A1 (en) | 2011-09-27 | 2013-04-04 | Bristol-Myers Squibb Company | Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| WO2013048982A1 (en) | 2011-09-27 | 2013-04-04 | Bristol-Myers Squibb Company | Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| US8993557B2 (en) | 2011-09-30 | 2015-03-31 | Bristol-Myers Squibb Company | Pyridinedione carboxamide inhibitors of endothelial lipase |
| US8946430B2 (en) | 2011-09-30 | 2015-02-03 | Bristol-Myers Squibb Company | Quinolinone carboxamide inhibitors of endothelial lipase |
| EP2760834B1 (de) | 2011-09-30 | 2016-11-16 | Bristol-Myers Squibb Company | Pyridindioncarboxamidhemmer von endothellipase |
| WO2013151877A1 (en) | 2012-04-03 | 2013-10-10 | Bristol-Myers Squibb Company | Pyrimidinedione carboxamide inhibitors of endothelial lipase |
| WO2013151923A1 (en) | 2012-04-03 | 2013-10-10 | Bristol-Myers Squibb Company | Pyrimidinone carboxamides as inhibitors of endothelial lipase |
| US9139578B2 (en) | 2012-07-09 | 2015-09-22 | Bristol-Myers Squibb Company | Amide or urea containing benzothiazole inhibitors of endothelial lipase |
| AR092854A1 (es) | 2012-07-09 | 2015-05-06 | Bristol Myers Squibb Co | Benzotiazoles que contienen sulfonilo como inhibidores de la lipasa endotelial |
| WO2014015088A1 (en) | 2012-07-19 | 2014-01-23 | Bristol-Myers Squibb Company | Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase |
| EP2895483A1 (de) | 2012-09-11 | 2015-07-22 | Bristol-Myers Squibb Company | Ketongebundene benzothiazolinhibitoren der endothellipase |
| US10173991B2 (en) | 2014-01-07 | 2019-01-08 | Bristol-Myers Squibb Company | Sulfone amide linked benzothiazole inhibitors of endothelial lipase |
| UY36630A (es) | 2015-04-17 | 2016-11-30 | Abbvie Inc | Moduladores tricíclicos de la señalización por tnf |
| WO2016168633A1 (en) | 2015-04-17 | 2016-10-20 | Abbvie Inc. | Indazolones as modulators of tnf signaling |
| US9879016B2 (en) | 2015-04-17 | 2018-01-30 | Abbvie Inc. | Indazolones as modulators of TNF signaling |
| WO2017214005A1 (en) | 2016-06-06 | 2017-12-14 | Bristol-Myers Squibb Company | 2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4340662A (en) * | 1979-09-10 | 1982-07-20 | Energy Conversion Devices, Inc. | Tellurium imaging composition |
| JPH1144927A (ja) * | 1997-07-28 | 1999-02-16 | Fuji Photo Film Co Ltd | 熱現像記録材料 |
| JP2002522385A (ja) * | 1998-08-03 | 2002-07-23 | イーライ・リリー・アンド・カンパニー | インドールｓＰＬＡ２インヒビター |
-
2004
- 2004-03-25 AT AT04723448T patent/ATE442139T1/de not_active IP Right Cessation
- 2004-03-25 ES ES04723448T patent/ES2330636T3/es not_active Expired - Lifetime
- 2004-03-25 US US10/544,910 patent/US20060211755A1/en not_active Abandoned
- 2004-03-25 DE DE602004023062T patent/DE602004023062D1/de not_active Expired - Fee Related
- 2004-03-25 EP EP04723448A patent/EP1610779B1/de not_active Expired - Lifetime
- 2004-03-25 WO PCT/US2004/006092 patent/WO2004093872A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004093872A1 (en) | 2004-11-04 |
| ES2330636T3 (es) | 2009-12-14 |
| EP1610779B1 (de) | 2009-09-09 |
| DE602004023062D1 (en) | 2009-10-22 |
| US20060211755A1 (en) | 2006-09-21 |
| EP1610779A1 (de) | 2006-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004023062D1 (en) | 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren | |
| NO20020305L (no) | Nye bisyklonukleosidanaloger | |
| RU2003122190A (ru) | Производные тетрагидропиридина, их получение и применение в качестве ингибиторов клеточной пролиферации | |
| TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| HRP20090195T1 (hr) | Inhibitori mitotičkih kinezina | |
| EA200600358A1 (ru) | Фенил- или пиридиламидные соединения в качестве антагонистов простагландина е2 | |
| TR200201506T2 (tr) | Terapötik maddeler olarak kinaz inhibitörleri | |
| ATE449099T1 (de) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
| ATE461193T1 (de) | Aminopyrone und ihre verwendung als atm inhibitoren | |
| CY1111596T1 (el) | Υποκατεστημενες ακετοφαινονες χρησιμες ως αναστολεις pde4 | |
| BR0313969A (pt) | Inibidores de oxitocina | |
| MY143245A (en) | 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases | |
| EA200701780A1 (ru) | Противоопухолевое средство | |
| MA64568B1 (fr) | Composés hétérocycliques capables d'activer sting | |
| ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
| ATE374750T1 (de) | Serotoninwiederaufnahme-inhibitoren | |
| CO5680420A2 (es) | Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4 | |
| ATE269851T1 (de) | Benzimidazole derivate | |
| DE60204468D1 (de) | Thiopyran-4-one als inhibitoren der dna protein kinase | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| TNSN04121A1 (en) | Acides 3 - (imidazolyl) - 2 - alkoxypropanoiques servant d'inhibiteurs de tafia | |
| DE60226971D1 (de) | Corticotropinfreisetzungsfaktor antagonisten | |
| ATE449773T1 (de) | Homomorpholinoxazolidinone als antibakterielle mittel | |
| TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
| JO2615B1 (en) | Benzimidazole compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |